Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 4HER2-positive Breast Cancer 2Non-squamous NSCLC 1Non Small Cell Lung 1HER2 Positive Breast Cancer 1

Interventions

pyrotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Non Small Cell Lung × pyrotinib × Clear all
NCT02834936 2025-08-28

A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
60 enrolled
Thoracic

Non Small Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡